Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction
Status:
Terminated
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Sexual dysfunction is a common side effect of selective serotonin reuptake inhibitors
(SSRIs). The hypotheses of this study are that:1. subjects with major depression or dysthymia
who are being treated with an SSRI and experiencing treatment-related sexual dysfunction will
experience less sexual dysfunction if they are switched to duloxetine, and 2. they will
experience either improved antidepressant response or no loss of antidepressant response.